# Brain Insulin Resistance in Mild Cognitive Impairment

> **NCT06116188** · — · UNKNOWN · sponsor: **Turku University Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment
- Positron Emission Tomography

## Interventions

- **DIAGNOSTIC_TEST:** FDG-PET study

## Key facts

- **NCT ID:** NCT06116188
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-12
- **Primary completion:** 2025-10-10
- **Final completion:** 2025-10-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06116188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06116188, "Brain Insulin Resistance in Mild Cognitive Impairment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06116188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*